lithium has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gu, J; Ma, K; Niu, J; Tao, S; Wang, P; Wang, S; Wei, S; Yang, L; Ye, M; Zhang, G; Zhang, L | 1 |
| Swartz, CM | 1 |
2 other study(ies) available for lithium and Demyelinating Diseases
| Article | Year |
|---|---|
Predicting signaling pathways regulating demyelination in a rat model of lithium-pilocarpine-induced acute epilepsy: A proteomics study.
Topics: Animals; Cell Differentiation; Demyelinating Diseases; Disease Models, Animal; Epilepsy; Hippocampus; Lithium; Male; MAP Kinase Signaling System; Myelin Sheath; p38 Mitogen-Activated Protein Kinases; Pilocarpine; Proteomics; Rats; Rats, Sprague-Dawley; Signal Transduction; Thymosin | 2021 |
Commentary on "Encephalopathy associated with rapid decrease of high levels of lithium".
Topics: Brain; Brain Damage, Chronic; Confusion; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lithium; Metabolic Clearance Rate; Neurons; Substance Withdrawal Syndrome | 1996 |